Matthew Ronsheim

Matthew Ronsheim serves as the Chief Operating Officer at Xenon Pharmaceuticals Inc. Previously, Matthew held the position of Director of Project Leadership and Global Pharmaceutical Commercialization at Merck. With a strong background in pharmaceutical operations and commercialization, Matthew Ronsheim brings valuable expertise to the biotechnology sector.